Regulatory Pathways

Examine global regulatory frameworks governing biosimilar approval and commercialization.Discuss FDA, EMA, WHO, PMDA, and emerging-market regulatory requirements.Focus on harmonization, extrapolation, interchangeability, and evolving guidelines.Explore strategies for navigating complex international regulatory pathways.Highlight opportunities for more efficient and consistent global approvals.

 

    Related Conference of Regulatory Pathways

    August 27-28, 2026

    30th Global Congress on Biotechnology

    Berlin, Germany
    September 21-22, 2026

    6th International Conference on Biomedicine & Pharmacotherapy

    Rome, Italy
    November 16-17, 2026

    8th International Conference on Biochemistry

    Tokyo, Japan
    November 25-26, 2026

    30th World Congress on Biotechnology

    Rome, Italy
    December 01-02, 2026

    21st World Congress on Biomarkers, Cancer Therapy & Clinical Research

    Dubai, UAE
    January 18-19, 2027

    7th Annual Congress on Antibiotics and Bacterial Infections

    Paris, France
    January 20-21, 2027

    33nd Asia Pacific Biotechnology Congress

    Dubai, UAE
    March 15-16, 2027

    8th Annual Congress on Biosimilars and Future Biotherapeutics

    San Francisco, USA
    April 27-28, 2027

    30th European Biotechnology Congress

    Paris, France
    June 07-08, 2027

    42nd International Conference on Next-Gen Biotechnology and Applications

    Atlanta, USA
    June 07-08, 2027

    28th Biotechnology Congress: Research & Innovations

    Atlanta, USA

    Regulatory Pathways Conference Speakers

      Recommended Sessions

      Related Journals

      Are you interested in